BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11400947)

  • 1. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study.
    Stern JM; Sullivan KM; Ott SM; Seidel K; Fink JC; Longton G; Sherrard DJ
    Biol Blood Marrow Transplant; 2001; 7(5):257-64. PubMed ID: 11400947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
    Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP
    J Bone Miner Res; 1999 Mar; 14(3):342-50. PubMed ID: 10027899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective assessment of bone turnover and clinical bone diseases after allogeneic hematopoietic stem-cell transplantation.
    Petropoulou AD; Porcher R; Herr AL; Devergie A; Brentano TF; Ribaud P; Pinto FO; Rocha V; Peffault de Latour R; Orcel P; Socié G; Robin M
    Transplantation; 2010 Jun; 89(11):1354-61. PubMed ID: 20216480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation.
    Yao S; Smiley SL; West K; Lamonica D; Battiwalla M; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2010 Aug; 16(8):1130-7. PubMed ID: 20188201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study.
    Schulte C; Beelen DW; Schaefer UW; Mann K
    Osteoporos Int; 2000; 11(4):344-53. PubMed ID: 10928225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pamidronate reduces bone loss after allogeneic stem cell transplantation.
    Grigg AP; Shuttleworth P; Reynolds J; Schwarer AP; Szer J; Bradstock K; Hui C; Herrmann R; Ebeling PR
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3835-43. PubMed ID: 16835281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone loss following hematopoietic stem cell transplantation: a long-term follow-up.
    Schulte CM; Beelen DW
    Blood; 2004 May; 103(10):3635-43. PubMed ID: 14630805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review.
    Tauchmanovà L; De Rosa G; Serio B; Fazioli F; Mainolfi C; Lombardi G; Colao A; Salvatore M; Rotoli B; Selleri C
    Cancer; 2003 May; 97(10):2453-61. PubMed ID: 12733144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation.
    Savani BN; Donohue T; Kozanas E; Shenoy A; Singh AK; Childs RW; Barrett AJ
    Biol Blood Marrow Transplant; 2007 May; 13(5):517-20. PubMed ID: 17448910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study.
    Gandhi MK; Lekamwasam S; Inman I; Kaptoge S; Sizer L; Love S; Bearcroft PW; Milligan TP; Price CP; Marcus RE; Compston JE
    Br J Haematol; 2003 May; 121(3):462-8. PubMed ID: 12716369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avascular necrosis of bone following allogeneic stem cell transplantation: MR screening and therapeutic options.
    Wiesmann A; Pereira P; Böhm P; Faul C; Kanz L; Einsele H
    Bone Marrow Transplant; 1998 Sep; 22(6):565-9. PubMed ID: 9758344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in trabecular bone score and bone mineral density following allogeneic hematopoietic stem cell transplantation.
    Lim Y; Baek KH; Kim HJ; Lee S; Lee JW; Kang MI
    Bone; 2019 Jul; 124():40-46. PubMed ID: 30959188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy.
    Yao S; McCarthy PL; Dunford LM; Roy DM; Brown K; Paplham P; Syta M; Lamonica D; Smiley S; Battiwalla M; Padmanabhan S; Hahn T
    Bone Marrow Transplant; 2008 Feb; 41(4):393-8. PubMed ID: 17994116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study.
    Kashyap A; Kandeel F; Yamauchi D; Palmer JM; Niland JC; Molina A; Fung H; Bhatia R; Krishnan A; Nademanee A; O'Donnell MR; Parker P; Rodriguez R; Snyder D; Spielberger R; Stein A; Nadler J; Forman SJ
    Biol Blood Marrow Transplant; 2000; 6(3A):344-51. PubMed ID: 10905772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss.
    Buchs N; Helg C; Collao C; Chapuis B; Slosman D; Bonjour JP; Rizzoli R
    Osteoporos Int; 2001; 12(10):880-6. PubMed ID: 11716193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low pretransplant bone-mineral density and rapid bone loss do not increase risk for avascular osteonecrosis after allogeneic hematopoietic stem cell transplantation.
    Schulte CM; Beelen DW
    Transplantation; 2005 Jun; 79(12):1748-55. PubMed ID: 15973180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.
    Kananen K; Volin L; Laitinen K; Alfthan H; Ruutu T; Välimäki MJ
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3877-85. PubMed ID: 15797959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
    Hautmann AH; Elad S; Lawitschka A; Greinix H; Bertz H; Halter J; Faraci M; Hofbauer LC; Lee S; Wolff D; Holler E
    Transpl Int; 2011 Sep; 24(9):867-79. PubMed ID: 21557780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.